{"id":201807,"date":"2024-10-19T12:53:42","date_gmt":"2024-10-19T12:53:42","guid":{"rendered":"https:\/\/pdfstandards.shop\/product\/uncategorized\/astm-e3238-2020\/"},"modified":"2024-10-25T05:31:05","modified_gmt":"2024-10-25T05:31:05","slug":"astm-e3238-2020","status":"publish","type":"product","link":"https:\/\/pdfstandards.shop\/product\/publishers\/astm\/astm-e3238-2020\/","title":{"rendered":"ASTM-E3238 2020"},"content":{"rendered":"
Scope<\/strong><\/p>\n 1.1<\/span> This test method provides a protocol for rapid and quantitative measurement of the chemoattractant capacity of a nanoparticulate material (nanoparticles and their aggregates and agglomerates).<\/p>\n<\/p><\/div>\n 1.2<\/span> Immune cells recruitment (by chemotaxis) plays a central role in the immune system function especially in the inflammatory process.<\/p>\n<\/p><\/div>\n 1.3<\/span> This test method uses an in vitro<\/span> model. In this model, peripheral blood human acute promyelocytic leukemia cells HL-60 are separated from control chemoattractant or test nanoparticulate material by a 3-\u00b5m pore size filter; the cell migration through the filter is monitored and quantified using the fluorescent dye calcein AM (Figs. 1 and<\/span> 2<\/span>).<\/p>\n FIG. 1<\/span> Chemotaxis Chamber (Boyden Chamber)<\/b><\/p>\n<\/p><\/div>\n<\/p><\/div>\n FIG. 2<\/span> Chemotaxis Assay<\/b><\/p>\n<\/p><\/div>\n